{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:19:36Z","timestamp":1787026776603,"version":"build-2736575974"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T00:00:00Z","timestamp":1692748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      The\n                      <jats:italic>Apolipoprotein E<\/jats:italic>\n                      (\n                      <jats:italic>APOE<\/jats:italic>\n                      ) epsilon (\u03b5) 4 allele is a well-established risk factor for late-onset Alzheimer\u2019s disease (AD). Reports on white ancestry populations have showed that age, sex, and ethnicity have different effects on the association between APOE genotype and AD. However, studies on Asian populations such as Taiwan Chinese populations are limited. This study aimed to evaluate the association between\n                      <jats:italic>APOE<\/jats:italic>\n                      genotype and AD in a Taiwan Chinese population, and to explore if the association varies by age and sex.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We conducted a case-control study in 725 patients with AD and 1,067 age- and sex- matched controls without dementia from a Taiwan Chinese population. Logistic regression models were used to test the association between AD and\n                      <jats:italic>APOE<\/jats:italic>\n                      genotypes. Secondary analyses considered age (&amp;lt;75 or \u226575 years old), and sex stratified models.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The risk of AD was significantly increased for people with at least one copy of\n                      <jats:italic>APOE<\/jats:italic>\n                      \u03b54 (OR = 2.52, 95% CI = 2.01\u20133.17,\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.001) and in a dose-dependent manner. Our results did not show an statistically significance different in AD risk when women and men carrying APOE\u03b54 were compared. Despite not reaching statistical significance, the risk of\n                      <jats:italic>APOE<\/jats:italic>\n                      \u03b54 for AD was higher among younger participants (OR = 3.21, 95% CI = 2.26\u20134.56,\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.001) compared to older ones (OR = 2.13, 95% CI = 1.53\u20132.97,\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.001). When considering both sex and age, the risk of AD was higher among older men carrying\n                      <jats:italic>APOE<\/jats:italic>\n                      \u03b54 (OR = 2.64, 95% CI = 1.51\u20134.60 in men; OR = 1.90, 95% CI = 1.26\u20132.86 in women), while women carrying\n                      <jats:italic>APOE<\/jats:italic>\n                      \u03b54 appeared to have an increased risk at a younger age (OR = 3.29, 95% CI = 2.20\u20134.93 in women; OR = 2.91, 95% CI = 1.40\u20136.05 in men).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>\n                      The\n                      <jats:italic>APOE<\/jats:italic>\n                      \u03b54 allele represents a major risk factor for AD in the Taiwanese population. The effect of\n                      <jats:italic>APOE<\/jats:italic>\n                      \u03b54 allele on AD risk appeared to be stronger among men aged 75 years or more and among younger women.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnagi.2023.1246592","type":"journal-article","created":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T12:43:56Z","timestamp":1692794636000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Age and sex differences in the association between APOE genotype and Alzheimer\u2019s disease in a Taiwan Chinese population"],"prefix":"10.3389","volume":"15","author":[{"given":"Ling-Chun","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Yueh","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Fang","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang-Pei","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan-Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Han","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,8,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/ana.24135","article-title":"Sex modifies the APOE-related risk of developing Alzheimer disease.","volume":"75","author":"Altmann","year":"2014","journal-title":"Ann. Neurol."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12068","article-title":"2020 Alzheimer\u2019s disease facts and figures.","year":"2020","journal-title":"Alzheimers Dement."},{"key":"B3","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S1474-4422(11)70072-2","article-title":"The projected effect of risk factor reduction on Alzheimer\u2019s disease prevalence.","volume":"10","author":"Barnes","year":"2011","journal-title":"Lancet Neurol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.jalz.2018.04.010","article-title":"Sex, amyloid, and APOE epsilon4 and risk of cognitive decline in preclinical Alzheimer\u2019s disease: Findings from three well-characterized cohorts.","volume":"14","author":"Buckley","year":"2018","journal-title":"Alzheimers Dement."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-18033-x","article-title":"Protective effect of apolipoprotein E epsilon 3 on sporadic Alzheimer\u2019s disease in the Chinese population: A meta-analysis.","volume":"12","author":"Chen","year":"2022","journal-title":"Sci. Rep."},{"key":"B6","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/ng0694-180","article-title":"Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease.","volume":"7","author":"Corder","year":"1994","journal-title":"Nat. Genet."},{"key":"B7","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families.","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"B8","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1093\/hmg\/7.1.43","article-title":"Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease.","volume":"7","author":"Cruts","year":"1998","journal-title":"Hum. Mol. Genet."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-014-0130-5","article-title":"Cardiovascular risk factors and future risk of Alzheimer\u2019s disease.","volume":"12","author":"de Bruijn","year":"2014","journal-title":"BMC Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1001\/jamaneurol.2017.1470","article-title":"Apolipoprotein E epsilon4 and risk factors for Alzheimer disease-let\u2019s talk about sex.","volume":"74","author":"Dubal","year":"2017","journal-title":"JAMA Neurol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/WAD.0b013e3181d1b99b","article-title":"Nonstroke cardiovascular disease and risk of Alzheimer disease and dementia.","volume":"24","author":"Eriksson","year":"2010","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"B12","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","article-title":"Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer disease meta-analysis consortium.","volume":"278","author":"Farrer","year":"1997","journal-title":"JAMA"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1212\/wnl.46.6.1749","article-title":"Epsilon 4 allele of apolipoprotein E increases risk of Alzheimer\u2019s disease in a Chinese population.","volume":"46","author":"Hong","year":"1996","journal-title":"Neurology"},{"key":"B14","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/s0022-510x(00)00443-3","article-title":"Genetic risk factors of sporadic Alzheimer\u2019s disease among Chinese in Taiwan.","volume":"181","author":"Hu","year":"2000","journal-title":"J. Neurol. Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1007\/s00702-002-0751-2","article-title":"Apolipoprotein E polymorphism in various dementias in Taiwan Chinese population.","volume":"109","author":"Huang","year":"2002","journal-title":"J. Neural Transm."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1212\/wnl.45.6.1092","article-title":"Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer\u2019s disease: A case-control study.","volume":"45","author":"Jarvik","year":"1995","journal-title":"Neurology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S1474-4422(19)30290-X","article-title":"Dementia in China: Epidemiology, clinical management, and research advances.","volume":"19","author":"Jia","year":"2020","journal-title":"Lancet Neurol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/s0021-9150(00)00570-0","article-title":"Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study.","volume":"154","author":"Lahoz","year":"2001","journal-title":"Atherosclerosis"},{"key":"B19","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1159\/000072804","article-title":"Apolipoprotein E in Taiwan Chinese patients with dementia.","volume":"16","author":"Lai","year":"2003","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"B20","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","article-title":"Apolipoprotein E and Alzheimer disease: Risk, mechanisms and therapy.","volume":"9","author":"Liu","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1212\/wnl.53.5.962","article-title":"ApoE genotype in relation to AD and cholesterol: A study of 2,326 Chinese adults.","volume":"53","author":"Liu","year":"1999","journal-title":"Neurology"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/srep04383","article-title":"Apolipoprotein E gene polymorphism and Alzheimer\u2019s disease in Chinese population: A meta-analysis.","volume":"4","author":"Liu","year":"2014","journal-title":"Sci. Rep."},{"key":"B23","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/wnl.34.7.939","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of health and human services task force on Alzheimer\u2019s disease.","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/0378-5122(92)90003-m","article-title":"The normal menopause transition.","volume":"14","author":"McKinlay","year":"1992","journal-title":"Maturitas"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1212\/wnl.43.11.2412-a","article-title":"The clinical dementia rating (CDR): Current version and scoring rules.","volume":"43","author":"Morris","year":"1993","journal-title":"Neurology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1001\/jamaneurol.2017.2188","article-title":"Apolipoprotein E genotype and sex risk factors for Alzheimer disease: A meta-analysis.","volume":"74","author":"Neu","year":"2017","journal-title":"JAMA Neurol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1161\/CIRCRESAHA.111.246876","article-title":"The intersection between aging and cardiovascular disease.","volume":"110","author":"North","year":"2012","journal-title":"Circ. Res."},{"key":"B28","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1001\/jama.1994.03510410028015","article-title":"Alzheimer\u2019s disease, apolipoprotein E4, and gender.","volume":"271","author":"Payami","year":"1994","journal-title":"JAMA"},{"key":"B29","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1086\/519795","article-title":"PLINK: A tool set for whole-genome association and population-based linkage analyses.","volume":"81","author":"Purcell","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"B30","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/0896-6273(93)90070-8","article-title":"Apolipoprotein E in sporadic Alzheimer\u2019s disease: Allelic variation and receptor interactions.","volume":"11","author":"Rebeck","year":"1993","journal-title":"Neuron"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1212\/wnl.43.8.1467","article-title":"Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer\u2019s disease.","volume":"43","author":"Saunders","year":"1993","journal-title":"Neurology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1365-2796.2006.01687.x","article-title":"Cardiovascular disease and Alzheimer\u2019s disease: Common links.","volume":"260","author":"Stampfer","year":"2006","journal-title":"J. Intern. Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1001\/jama.279.10.751","article-title":"The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics.","volume":"279","author":"Tang","year":"1998","journal-title":"JAMA"},{"key":"B34","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1007\/s11682-013-9272-x","article-title":"Apolipoprotein E, gender, and Alzheimer\u2019s disease: An overlooked, but potent and promising interaction.","volume":"8","author":"Ungar","year":"2014","journal-title":"Brain Imaging Behav."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/s41525-021-00178-9","article-title":"Genetic profiles of 103,106 individuals in the Taiwan Biobank provide insights into the health and history of Han Chinese.","volume":"6","author":"Wei","year":"2021","journal-title":"NPJ Genom. Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"371","DOI":"10.2147\/CIA.S73396","article-title":"Associations between apolipoprotein E gene polymorphisms and Alzheimer\u2019s disease risk in a large Chinese Han population.","volume":"10","author":"Wu","year":"2015","journal-title":"Clin. Interv. Aging"},{"key":"B37","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41582-019-0228-7","article-title":"Apolipoprotein E and Alzheimer disease: Pathobiology and targeting strategies.","volume":"15","author":"Yamazaki","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1177\/1533317510397330","article-title":"Application of AD8 questionnaire to screen very mild dementia in Taiwanese.","volume":"26","author":"Yang","year":"2011","journal-title":"Am. J. Alzheimers Dis. Other Dement."},{"key":"B39","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.cger.2009.07.007","article-title":"The burden of cardiovascular disease in the elderly: Morbidity, mortality, and costs.","volume":"25","author":"Yazdanyar","year":"2009","journal-title":"Clin. Geriatr. Med."}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2023.1246592\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T12:44:00Z","timestamp":1692794640000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2023.1246592\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,23]]},"references-count":39,"alternative-id":["10.3389\/fnagi.2023.1246592"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2023.1246592","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,23]]},"article-number":"1246592"}}